DEG0014632MA - - Google Patents
Info
- Publication number
- DEG0014632MA DEG0014632MA DEG0014632MA DE G0014632M A DEG0014632M A DE G0014632MA DE G0014632M A DEG0014632M A DE G0014632MA
- Authority
- DE
- Germany
- Prior art keywords
- vol
- reported
- indanedione
- soc
- bis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000126 substance Substances 0.000 claims description 15
- HHLFWLYXYJOTON-UHFFFAOYSA-N Glyoxylic acid Natural products OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 claims description 4
- UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-Indandione Chemical compound C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 claims description 3
- -1 alkyl glyoxylate Chemical compound 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000003172 aldehyde group Chemical group 0.000 claims description 2
- 125000005907 alkyl ester group Chemical group 0.000 claims description 2
- 230000023555 blood coagulation Effects 0.000 claims description 2
- 239000003701 inert diluent Substances 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 229940079593 drugs Drugs 0.000 claims 2
- VRWAQWUCMVPRHV-UHFFFAOYSA-N 2,2-bis(1,3-dioxoinden-2-yl)acetic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C1C(C(=O)O)C1C(=O)C2=CC=CC=C2C1=O VRWAQWUCMVPRHV-UHFFFAOYSA-N 0.000 claims 1
- 241001340526 Chrysoclista linneella Species 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 102100015239 F2 Human genes 0.000 description 3
- 229940039716 Prothrombin Drugs 0.000 description 3
- 108010094028 Prothrombin Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000875 corresponding Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- TYEYBOSBBBHJIV-UHFFFAOYSA-M 2-oxobutanoate Chemical compound CCC(=O)C([O-])=O TYEYBOSBBBHJIV-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-M Sodium 2-anthraquinonesulfonate Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)[O-])=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 230000000069 prophylaxis Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000003128 rodenticide Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001732 thrombotic Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical class C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1620024C3 (de) | 3'-Pyridylmethyl-2-(4-chlorphenoxy)-2-methylpropionat | |
DE2438399C3 (de) | a-substituierte Benzhydrolderivate und ihre Salze, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben | |
DE3021169A1 (de) | Pivaloyloxymethyl-2-propylpentanoat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel | |
DE1470074C3 (de) | 1,2,3,4,6,7-Hexahydro-l lbH-benzo eckige Klammer auf a eckige Klammer zu chinolizine sowie deren Acetate und/oder phsiologisch verträgliche Säureadditionssalze sowie Verfahren zu ihrer Herstellung | |
DEG0014632MA (fr) | ||
DE946894C (de) | Verfahren zur Herstellung von 2, 2'-Carboxy- bzw. 2, 2'-Carbalkoxymethylen-bis-1, 3-indandionen | |
DE69132143T2 (de) | Neue pilocarpinderivate und verfahren zu ihrer herstellung | |
DE2502504B2 (de) | Phenothiazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DE2528194C2 (de) | Benzhydryloxyäthylamin-Derivate, deren Salze, Verfahren zur Herstellung derselben und solche enthaltende Arzneimittel | |
DE1593924C3 (de) | 6-Guanidomethyl-1,4-benzodioxan und dessen pharmakologisch nichtgiftige Säureadditionssalze sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
DE2835043A1 (de) | Bromhexin-derivate mit gegenueber bromhexin geringerer schleimloesender und hustenlindernder wirkung und geringerer toxizitaet | |
EP0266336B1 (fr) | 1-[3-(2-Dialcoylaminoéthoxy)-2-thiényl]-3-phényl-1-propanones et leurs sels d'addition d'acide, leur procédé de préparation et compositions pharmaceutiques les contenant | |
DE2560602C2 (de) | Sauerstoffhaltige Diarylamidine | |
DE2725245A1 (de) | Methylaminderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen | |
DE1567046A1 (de) | Parasitizides,insbesondere fungizides Mittel | |
DE2406849C3 (de) | Nicotinsäure-trans-3,3,5-trimethylcyclohex-1-yl-ester, Verfahren zu seiner Herstellung und diesen Ester enthaltendes Arzneimittel | |
DE1291748B (de) | 1, 3-Dioxan-2-carbonsaeuren und deren Alkalisalze sowie Verfahren zu deren Herstellung | |
DE1618310C3 (fr) | ||
DE1593644C3 (fr) | ||
DE2129991C3 (de) | Verfahren zur Herstellung von 2-(4,5-Dihydro-5-propyl-2(3H)-furyliden) -1,3-cyclopentandion | |
DE2000435C (de) | alpha-Isopropyl-alpha- eckige Klammer auf(N-methyl-N-homoveratryl)-gamma-aminopropyl eckige Klammer zu -3,4-Äthylendioxyphenylacetonitril und dessen nicht toxische Säureadditionssalze | |
DE1518004C3 (de) | N-Carboxymethyl-2-(4-chlorphenoxy)· 2-methylpropionamid, Verfahren zu dessen Herstellung, und Arzneimittel, die diese Verbindung enthalten | |
DE1468212C (fr) | ||
DE1770091C3 (de) | Ester von 3-Dimethylsulfamoyl-IOhydroxyäthyl-piperidinopropyl-phenothiazin | |
DE1795270C3 (de) | 1 -Hydroxy-2-pyridone |